$984.62 travel Payment -- Teva Pharmaceuticals to Dr. Jeffrey Campbell
Psychiatrist Received Travel Payment from Teva Pharmaceuticals for Eliquis
This page provides a detailed analysis of a $984.62 travel payment from Teva Pharmaceuticals to Dr. Jeffrey Campbell. Data is from the CMS Open Payments (Sunshine Act) database.
Payment Details
| Field | Value |
|---|---|
| Amount | $984.62 |
| Payment Type | travel |
| Payment Nature | Travel and Lodging |
| Pharmaceutical Company | Teva Pharmaceuticals |
| Physician | Dr. Jeffrey Campbell |
| NPI Number | 1850903205 |
| Physician Specialty | Psychiatry |
| Location | City, TN |
| Date of Payment | 2024-04-28 |
| Related Drug/Device | Eliquis |
| Conflict Assessment | Low -- Routine |
AI-Powered Analysis of This Payment
The following analysis was generated by artificial intelligence to help patients understand the context, significance, and implications of this pharmaceutical payment. This analysis is not medical or legal advice.
Teva Pharmaceuticals made a $984.62 travel payment to Jeffrey Campbell, a Psychiatry specialist in City, TN. The payment was associated with Eliquis. A payment of $984.62 was made for travel and lodging. The payment was associated with the drug Eliquis. This payment was made to Dr. Jeffrey Campbell, a psychiatrist.
Patient Guidance: What This Payment Means for You
If you are a patient prescribed Eliquis, understand that your doctor may receive payments from pharmaceutical companies for various reasons, including travel expenses. Always discuss your treatment options with your healthcare provider and ask about alternatives.
Payment Context: Is This Amount Normal?
For a psychiatrist, travel and lodging payments are not uncommon, especially if related to educational events or conferences concerning medications like Eliquis.
Regulatory Context: Sunshine Act Requirements
This payment falls under the Sunshine Act, requiring disclosure of financial relationships between drug manufacturers and healthcare providers.
Related Topics
This payment is related to the following healthcare transparency topics:
- pharmaceutical-payments
- physician-payments
- travel-expenses
- psychiatry
- cardiovascular-drugs
- open-payments
Understanding travel Payments
Travel and lodging payments cover transportation and accommodation expenses for physicians attending conferences, advisory board meetings, or speaking engagements sponsored by pharmaceutical companies. These payments can be substantial, particularly for international travel or multi-day events.
Frequently Asked Questions About This Payment
What was this $984.62 payment for?
This was a travel payment of $984.62 from Teva Pharmaceuticals to Jeffrey Campbell, categorized as "Travel and Lodging". It was associated with Eliquis. The payment was reported under the Sunshine Act (CMS Open Payments).
Does Jeffrey Campbell accept pharmaceutical money?
Yes, Jeffrey Campbell received this $984.62 payment from Teva Pharmaceuticals. Under the Sunshine Act, pharmaceutical companies must report all payments to physicians exceeding $10. You can view Jeffrey Campbell's full payment history on the CMS Open Payments database or on this site.
Is it legal for doctors to accept pharma payments?
Yes, it is legal for physicians to receive payments from pharmaceutical companies. The Physician Payments Sunshine Act (2010) requires transparency by mandating that companies report all payments exceeding $10 to CMS. These payments include consulting fees, meals, travel, speaking fees, and research grants. The law does not prohibit payments but ensures public disclosure.
Should I be concerned about this travel payment?
A travel payment of $984.62 should be evaluated in context. Payment does not imply wrongdoing, but patients have the right to ask their doctor about pharmaceutical relationships.
How do I talk to my doctor about pharma relationships?
You can ask your doctor directly: "Do you receive payments from pharmaceutical companies?" and "Does this affect which medications you prescribe?" Most doctors will answer honestly. You can also verify payment data yourself through CMS Open Payments (openpaymentsdata.cms.gov). Consider asking about generic alternatives and whether the prescribed medication is the best option regardless of manufacturer relationships.
What types of pharma payments are most concerning?
Ownership interests and large consulting/speaking fees are generally considered more significant than meals or small educational grants. Research payments typically fund clinical studies and are common in academic medicine. The total volume and concentration of payments from a single company may be more telling than any individual payment. Patterns matter more than individual transactions.
Does pharma money affect what my doctor prescribes?
Research shows that even small payments can influence prescribing behavior. Studies published in JAMA Internal Medicine found that physicians who received meals costing as little as $20 were more likely to prescribe the promoted brand-name drug. However, many physician-industry interactions are legitimate professional activities. The key is transparency and awareness.
How does this compare to other doctors in Psychiatry?
To compare this payment against Psychiatry averages, check the full specialty breakdown on CMS Open Payments. Payment amounts vary widely by specialty and type. Psychiatry physicians may receive payments for consulting, speaking, or research that are standard for the field. Individual payments should be evaluated in the context of the doctor's full payment history.
What does this payment reveal about Jeffrey Campbell's relationship with Teva Pharmaceuticals?
The payment was specifically for travel and lodging expenses. This $984.62 travel payment is part of the transparency data reported under the Sunshine Act.
Is this payment amount typical for Psychiatry?
Eliquis is a medication often prescribed for cardiovascular conditions.
What should patients do after learning about this payment?
If you are a patient prescribed Eliquis, understand that your doctor may receive payments from pharmaceutical companies for various reasons, including travel expenses.
What else should I know about this travel payment?
The payment occurred on April 28, 2024.
Related Reports
Data from CMS Open Payments. Payment does not imply wrongdoing. Consult your healthcare provider about any concerns.